HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Changes in regulatory T cells after rituximab in two patients with refractory myasthenia gravis.

AuthorsValentina Catzola, Alessandra Battaglia, Alexia Buzzonetti, Marco Fossati, Flavia Scuderi, Andrea Fattorossi, Amelia Evoli
JournalJournal of neurology (J Neurol) Vol. 260 Issue 8 Pg. 2163-5 (Aug 2013) ISSN: 1432-1459 [Electronic] Germany
PMID23749295 (Publication Type: Case Reports, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal, Murine-Derived
  • Immunosuppressive Agents
  • Receptors, Cholinergic
  • Rituximab
  • MUSK protein, human
  • Receptor Protein-Tyrosine Kinases
Topics
  • Adult
  • Antibodies, Monoclonal, Murine-Derived (therapeutic use)
  • Female
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Middle Aged
  • Myasthenia Gravis (drug therapy, immunology)
  • Receptor Protein-Tyrosine Kinases (immunology)
  • Receptors, Cholinergic (immunology)
  • Rituximab
  • T-Lymphocytes, Regulatory (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: